Lilly added that the study also showed Ebglyss was able to achieve meaningful improvements in patients with difficult-to-treat dermatitis on the face and hands. The company said patients in the ...

NHS England has been cleared to allow prescribing of Almirall’s Ebglyss for some people with atopic dermatitis, giving them the option of a therapy that only needs to be injected once a month.

The company's dermatology business is driven by Ebglyss (lebrikizumab) and Ilumetri (tildrakizumab). The company further reveals that these medications are anticipated to lead to over EUR800m ($ ...